Dr. Joseph Cox is an associate professor in the Department of Epidemiology, Biostatistics and Occupational Health in the Division of Infectious Diseases of the Faculty of Medicine at McGill University and an investigator at the McGill University Health Centre Research Institute.

He earned his bachelor’s degree and medical degree at Dalhousie University and then his master’s degree in epidemiology and residency training in public health and preventative medicine at McGill University.

Dr. Cox’s research focuses on involving vulnerable populations, evaluating the impact of prevention and care interventions for vulnerable populations, and advancing the clinical method and care of patients with substance use disorders and patients living with multi-morbidities.

He is a principal investigator for CTN 264, a study investigating the relationship between food insecurity and health and behavioural outcomes in HIV-HCV co-infection. He is a co-investigator for CTN 222, which is looking at possible reasons why liver disease progresses more rapidly in people co-infected with HIV and hepatitis C despite the use of highly active antiretroviral therapy, as well as a co-investigator for CTN 286, which evaluates whether switching from current cART to Triumeq in addition to adherence support will enhance virologic control in vulnerable populations. He has also contributed to over a dozen CTN research publications since 2012.

Dr. Joseph Cox